Success Stories: EB-1A Approved for a Research Associate in Texas in the Field of Pharmaceutical Science
Client’s Testimonial:
Thank you very much for all your help.
On March 23rd, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Research Associate in the Field of Pharmaceutical Science (Approval Notice)
Position at the Time of Case Filing: Research Associate
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Texas
Approval Notice Date: March 23rd, 2015
Processing Time: 24 days (7 days after Requesting Premium Processing)
In this case we were offered the opportunity to work with a pharmaceutical scientist from India whose highly specialized work focused on a diverse range of stroke-related topics. He had produced 8 peer-reviewed journal articles, 1 thesis publication, and given 25 presentations at national and international conferences; altogether our client’s work had received no fewer than 149 citations from independent and leading researchers at prestigious institutions and organizations around the world, showing its major significance within his field. He had also reviewed 25 manuscripts for 10 prominent, internationally-circulated journals. An independent recommender endorsed our client’s superior level of expertise: “Few others have managed to produce the extensive results that [Client] has, and I have no reluctance in proclaiming that he is an undisputed leader in brain disease and disorder, and should be granted the continued pursuit of his research.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmaceutical Science, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 24 days (7 days after requesting Premium Processing).